Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FCRQ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,752
Award facts
- Contract value 100% obligated
- $49,752.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $49,752.39 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for Stelara 90 mg/mL syringes, awarded on December 19, 2025, with an ultimate completion date of January 13, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order will be fulfilled from the company's Park Ridge, Illinois location.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy established to provide comprehensive pharmaceutical and medical consumables support to Department of Defense healthcare facilities worldwide. The parent IDC, awarded on November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period followed by three 30-month option periods. This delivery order for the immunosuppressant biologic Stelara represents one of numerous pharmaceutical products DMS Pharmaceutical Group supplies to support recurring medical supply needs across the military healthcare system globally.
Quick answers
Who was awarded contract SPE2DR26FCRQ9?
SPE2DR26FCRQ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCRQ9 worth?
The government has obligated $49,752 on SPE2DR26FCRQ9.
Is contract SPE2DR26FCRQ9 an order under another contract?
Yes. SPE2DR26FCRQ9 is a delivery order under SPE2DR25D9168, an indefinite delivery contract.
Was contract SPE2DR26FCRQ9 competed?
The extent of competition for SPE2DR26FCRQ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award